APYX MEDICAL CORPORATION REPORTS PRELIMINARY FOURTH QUARTER AND FULL YEAR 2021 REVENUE RESULTSApyxMedical2025-12-12T19:21:47+00:00January 10, 2022|Read More
APYX MEDICAL CORPORATION REPORTS THIRD QUARTER 2021 FINANCIAL RESULTS AND UPDATES FULL YEAR 2021 OUTLOOKApyxMedical2025-12-12T19:22:26+00:00November 11, 2021|Read More
APYX MEDICAL CORPORATION TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES IN NOVEMBER AND DECEMBERApyxMedical2025-12-12T19:29:20+00:00November 10, 2021|Read More
APYX MEDICAL CORPORATION TO RELEASE THIRD QUARTER OF FISCAL YEAR 2021 FINANCIAL RESULTS ON NOVEMBER 11, 2021ApyxMedical2025-12-12T19:29:47+00:00October 4, 2021|Read More
APYX MEDICAL CORPORATION ANNOUNCES APPOINTMENT OF WENDY LEVINE TO THE COMPANY’S BOARD OF DIRECTORSApyxMedical2025-12-12T19:30:11+00:00August 30, 2021|Read More
APYX MEDICAL CORPORATION REPORTS SECOND QUARTER 2021 FINANCIAL RESULTS AND UPDATES FULL YEAR 2021 OUTLOOKApyxMedical2025-12-12T19:30:49+00:00August 12, 2021|Read More
APYX MEDICAL CORPORATION TO RELEASE SECOND QUARTER OF FISCAL YEAR 2021 FINANCIAL RESULTS ON AUGUST 12, 2021ApyxMedical2025-12-12T19:31:16+00:00July 12, 2021|Read More
APYX MEDICAL CORPORATION TO PARTICIPATE IN THE JMP SECURITIES LIFE SCIENCES CONFERENCEApyxMedical2025-12-12T19:31:44+00:00June 3, 2021|Read More
APYX MEDICAL CORPORATION ANNOUNCES FDA 510(K) SUBMISSION FOR THE USE OF RENUVION IN DERMAL RESURFACING PROCEDURESApyxMedical2025-12-12T19:32:06+00:00June 1, 2021|Read More
APYX MEDICAL CORPORATION REPORTS FIRST QUARTER 2021 FINANCIAL RESULTS AND UPDATES FULL YEAR 2021 OUTLOOKApyxMedical2025-12-12T19:32:32+00:00May 12, 2021|Read More
APYX MEDICAL CORPORATION TO RELEASE FIRST QUARTER OF FISCAL YEAR 2021 FINANCIAL RESULTS ON MAY 12, 2021ApyxMedical2025-12-12T19:32:54+00:00April 12, 2021|Read More
APYX MEDICAL CORPORATION REPORTS FOURTH QUARTER AND FULL YEAR 2020 FINANCIAL RESULTS; INTRODUCES FULL YEAR 2021 FINANCIAL OUTLOOKApyxMedical2025-12-12T19:33:27+00:00March 31, 2021|Read More
APYX MEDICAL CORPORATION TO RELEASE FOURTH QUARTER AND FISCAL YEAR 2020 FINANCIAL RESULTS ON MARCH 31, 2021ApyxMedical2025-12-12T19:33:50+00:00February 1, 2021|Read More
APYX MEDICAL CORPORATION REPORTS PRELIMINARY FULL YEAR AND FOURTH QUARTER 2020 REVENUE RESULTSApyxMedical2025-12-12T19:34:13+00:00January 13, 2021|Read More
APYX MEDICAL CORPORATION TO PARTICIPATE IN THE ICR CONFERENCE 2021ApyxMedical2025-12-12T19:34:37+00:00January 5, 2021|Read More
APYX MEDICAL CORPORATION ANNOUNCES APPROVAL FROM FDA TO BEGIN PHASE II OF U.S. IDE STUDYApyxMedical2025-12-12T19:34:58+00:00November 23, 2020|Read More
